title: Protection of adult rat cardiac myocytes from ischemic cell death: role of caveolar microdomains and delta-opioid receptors.
abstract: The role of caveolae, membrane microenvironments enriched in signaling molecules, in myocardial ischemia is poorly defined. In the current study, we used cardiac myocytes prepared from adult rats to test the hypothesis that opioid receptors (OR), which are capable of producing cardiac protection in vivo, promote cardiac protection in cardiac myocytes in a caveolae-dependent manner. We determined protein expression and localization of delta-OR (DOR) using coimmunohistochemistry, caveolar fractionation, and immunoprecipitations. DOR colocalized in fractions with caveolin-3 (Cav-3), a structural component of caveolae in muscle cells, and could be immunoprecipitated by a Cav-3 antibody. Immunohistochemistry confirmed plasma membrane colocalization of DOR with Cav-3. Cardiac myocytes were subjected to simulated ischemia (2 h) or an ischemic preconditioning (IPC) protocol (10 min ischemia, 30 min recovery, 2 h ischemia) in the presence and absence of methyl-beta-cyclodextrin (MbetaCD, 2 mM), which binds cholesterol and disrupts caveolae. We also assessed the cardiac protective effects of SNC-121 (SNC), a selective DOR agonist, on cardiac myocytes with or without MbetaCD and MbetaCD preloaded with cholesterol. Ischemia, simulated by mineral oil layering to inhibit gas exchange, promoted cardiac myocyte cell death (trypan blue staining), a response blunted by SNC (37 +/- 3 vs. 59 +/- 3% dead cells in the presence and absence of 1 muM SNC, respectively, P < 0.01) or by use of the IPC protocol (35 +/- 4 vs. 62 +/- 3% dead cells, P < 0.01). MbetaCD treatment, which disrupted caveolae (as detected by electron microscopy), fully attenuated the protective effects of IPC or SNC, resulting in cell death comparable to that of the ischemic group. By contrast, SNC-induced protection was not abrogated in cells incubated with cholesterol-saturated MbetaCD, which maintained caveolae structure and function. These findings suggest a key role for caveolae, perhaps through enrichment of signaling molecules, in contributing to protection of cardiac myocytes from ischemic damage.
authors.affiliation: Department of Pharmacology, University of California, San Diego, VA San Diego Healthcare System, San Diego, CA 92161-5085, USA. hepatel@ucsd.edu
authors.forename: Hemal H
authors.initials: HH
authors.lastname: Patel
authors.forename: Brian P
authors.initials: BP
authors.lastname: Head
authors.forename: Heidi N
authors.initials: HN
authors.lastname: Petersen
authors.forename: Ingrid R
authors.initials: IR
authors.lastname: Niesman
authors.forename: Diane
authors.initials: D
authors.lastname: Huang
authors.forename: Garrett J
authors.initials: GJ
authors.lastname: Gross
authors.forename: Paul A
authors.initials: PA
authors.lastname: Insel
authors.forename: David M
authors.initials: DM
authors.lastname: Roth
mesh_terms: D000818:Animals; D021941:Caveolae / Q000378:metabolism* / Q000648:ultrastructure*; D002478:Cells, Cultured; D017202:Myocardial Ischemia / Q000378:metabolism* / Q000473:pathology* / Q000517:prevention & control; D032383:Myocytes, Cardiac / Q000378:metabolism* / Q000473:pathology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D017465:Receptors, Opioid, delta / Q000378:metabolism*
chemical_list: D017465:Receptors, Opioid, delta